title: Fulminant rhabdomyolysis after prolonged radical prostatectomy managed with continuous veno-venous haemodialysis, regional citrate anticoagulation, and a polysulphone high-flux filter.
authors.forename: S
authors.initials: S
authors.lastname: Hafner
authors.forename: U
authors.initials: U
authors.lastname: Ehrmann
authors.forename: F
authors.initials: F
authors.lastname: Jentzmik
authors.forename: W
authors.initials: W
authors.lastname: Klingler
authors.forename: M
authors.initials: M
authors.lastname: Georgieff
authors.forename: G
authors.initials: G
authors.lastname: Froeba
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001672:Biocompatible Materials / Q000627:therapeutic use; D019343:Citric Acid / Q000627:therapeutic use*; D015314:Dialysis Solutions / Q000627:therapeutic use; D017583:Hemodiafiltration / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011108:Polymers / Q000627:therapeutic use*; D011468:Prostatectomy / Q000009:adverse effects*; D006435:Renal Dialysis / Q000379:methods*; D012206:Rhabdomyolysis / Q000209:etiology / Q000628:therapy*; D013450:Sulfones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D001672:Biocompatible Materials; D015314:Dialysis Solutions; D011108:Polymers; D013450:Sulfones; C017662:polysulfone P 1700; D019343:Citric Acid